These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9578004)

  • 1. The utility of the lh/lh mutant mouse as a animal model of human absence epilepsy.
    Kamin M; Cazzaniga EK; Raina MK; Shank RP
    Epilepsia; 1998 Feb; 39(2):232-3. PubMed ID: 9578004
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice.
    Nakamura J; Tamura S; Kanda T; Ishii A; Ishihara K; Serikawa T; Yamada J; Sasa M
    Eur J Pharmacol; 1994 Mar; 254(1-2):83-9. PubMed ID: 8206119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate for epilepsy.
    Med Lett Drugs Ther; 1997 May; 39(1001):51-2. PubMed ID: 9164447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacology and clinical results of topiramate (TOPINA Tablets), a new antiepileptic drug].
    Kobayashi M; Watanabe M; Nakamura J
    Nihon Yakurigaku Zasshi; 2008 Jul; 132(1):45-52. PubMed ID: 18622103
    [No Abstract]   [Full Text] [Related]  

  • 6. [Topiramate--a new anti-epileptic agent].
    Nervenarzt; 1996 Feb; 67(2 Suppl):1-8. PubMed ID: 9022393
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS.
    Rigoulot MA; Boehrer A; Nehlig A
    Epilepsia; 2003 Jan; 44(1):14-9. PubMed ID: 12581224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topiramate: a broad-spectrum antiepileptic drug? Sixth meeting of the European Neurological Society. Den Haag, 8 June 1996].
    Fortschr Neurol Psychiatr; 1996 Sep; 64(9 Suppl):1-8. PubMed ID: 9022373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Weight loss with topiramate in patients with epileptic disorders].
    Carnero Fernández M; Morales Gorría MJ; Corredera García E; Del Campo Pérez V
    Med Clin (Barc); 2005 Apr; 124(16):636-7. PubMed ID: 15871784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Topiramate in the therapy of epilepsy. Complex action mechanism--multiple action].
    Nervenarzt; 1999 Oct; 70(10 Suppl Komplexer):1-4. PubMed ID: 10555524
    [No Abstract]   [Full Text] [Related]  

  • 11. A pilot study of topiramate in childhood absence epilepsy.
    Piña-Garza JE; Schwarzman L; Wiegand F; Hulihan J
    Acta Neurol Scand; 2011 Jan; 123(1):54-9. PubMed ID: 20219018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of new and established antiepileptic drugs.
    Leppik IE
    Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436
    [No Abstract]   [Full Text] [Related]  

  • 13. AMPA blockade may be the mechanism underlying the efficacy of topiramate in PTSD.
    Zullino DF; Krenz S; Besson J
    J Clin Psychiatry; 2003 Feb; 64(2):219-20. PubMed ID: 12633137
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
    François J; Boehrer A; Nehlig A
    Epilepsia; 2008 Mar; 49(3):393-9. PubMed ID: 17822432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Challenges in epilepsy therapy: start low, go slow. 72nd Congress of the German Society for Neurology. Topiramate--a valuable new tool for the therapy of focal epilepsy? 1 October 1999, Magdeburg].
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12 Suppl Herausford):1-4. PubMed ID: 10686677
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular pharmacology of topiramate: managing seizures and preventing migraine.
    White HS
    Headache; 2005 Apr; 45 Suppl 1():S48-56. PubMed ID: 15833090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.
    Russo E; Constanti A; Ferreri G; Citraro R; De Sarro G
    Neuropharmacology; 2004 May; 46(6):865-78. PubMed ID: 15033346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER).
    Kanda T; Kurokawa M; Tamura S; Nakamura J; Ishii A; Kuwana Y; Serikawa T; Yamada J; Ishihara K; Sasa M
    Life Sci; 1996; 59(19):1607-16. PubMed ID: 8913326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.